Dilireba Shataer

Dr. Dilireba Shataer


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2024 in Foods
Verified
Journal Article
Open access
PDF file
JLJing Lu
Jing Lu
DSDilireba Shataer
Dilireba Shataer
HYHuizhen Yan
Huizhen Yan
XDXiaoxiao Dong
Xiaoxiao Dong
MZMinwei Zhang
Minwei Zhang
WLWang Liang
Wang Liang
In recent years, the prevalence of non-alcoholic fatty liver disease (NAFLD) has risen annually, yet due to the intricacies of its pathogenesis and therapeutic challenges, there remains no definitive medication for this condition. This review explores the intricate relationship between the intestinal microbiome and the pathogenesis of NAFLD, emphasizing the substantial roles played by Lactobacillus plantarum and Bifidobacterium bifidum. These probiotics manipulate lipid synthesis genes and phosphorylated proteins through pathways such as the AMPK/Nrf2, LPS-TLR4-NF-κB, AMPKα/PGC-1α, SREBP-1/FAS, and SREBP-1/ACC signaling pathways to reduce hepatic lipid accumulation and oxidative stress, key components of NAFLD progression. By modifying the intestinal microbial composition and abundance, they combat the overgrowth of harmful bacteria, alleviating the inflammatory response precipitated by dysbiosis and bolstering the intestinal mucosal barrier. Furthermore, they participate in cellular immune regulation, including CD4+ T cells and Treg cells, to suppress systemic inflammation. L. plantarum and B. bifidum also modulate lipid metabolism and immune reactions by adjusting gut metabolites, including propionic and butyric acids, which inhibit liver inflammation and fat deposition. The capacity of probiotics to modulate lipid metabolism, immune responses, and gut microbiota presents an innovative therapeutic strategy. With a global increase in NAFLD prevalence, these insights propose a promising natural method to decelerate disease progression, avert liver damage, and tackle associated metabolic issues, significantly advancing microbiome-focused treatments for NAFLD.

8 November 2024 in Foods
Verified
Journal Article
Open access
NTNuersiman Tuerhong
Nuersiman Tuerhong
WLWang Liang
Wang Liang
JCJie Cui
Jie Cui
DSDilireba Shataer
Dilireba Shataer
HYHuizhen Yan
Huizhen Yan
JLJing Lu
Jing Lu
This study explores the functional attributes of Lactiplantibacillus plantarum (L. plantarum) strains isolated from fermented tomato juice, focusing on their physiological, biochemical, and probiotic characteristics. The identified 66 gram-positive strains included 36 L. plantarum ones, which exhibited robust growth in acidic environments (pH 2.0–5.0) and utilization of various carbohydrates. Notably, seven strains outperformed a commercial strain in extreme acidic conditions. Antioxidant activity varied, with strain A24 showing the highest hydroxyl radical scavenging ability, while strains with high surface hydrophobicity had lower DPPH scavenging activity, indicating no direct correlation between these properties. Strains also showed strain-specific differences in carbohydrate utilization and antibiotic resistance, with some resistant to gentamicin and ciprofloxacin. Survival rates under simulated gastrointestinal conditions were strain-specific, with some strains demonstrating high survival rates, indicating their potential as probiotics. Furthermore, 13 strains used as fermentation starters in tomato juice significantly enhanced antioxidant activity and reduced pH and total soluble solids, indicating efficient sugar utilization and lactic acid production. These findings suggest that L. plantarum strains are well-suited for functional food fermentation and probiotic applications, with strain-specific traits offering versatility for use in acidic food products and probiotic formulations.

1 January 2025 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
DSDilireba Shataer
Dilireba Shataer
SCSiyu Cao
Siyu Cao
XLXin Liu
Xin Liu
KAKailibinuer Aierken
Kailibinuer Aierken
PBPronaya Bhattacharya
Pronaya Bhattacharya
Haipeng LiuHaipeng Liu
Haipeng Liu

8 July 2025 in Current Research in Food Science
Verified
Journal Article
Open access
JLJing Lu
Jing Lu
XDXiaoxiao Dong
Xiaoxiao Dong
ZGZiqi Gao
Ziqi Gao
HYHuizhen Yan
Huizhen Yan
DSDilireba Shataer
Dilireba Shataer
SZShengyang Zhou
Shengyang Zhou
Metabolic dysfunction-associated steatotic liver disease (MASLD) is recognized as one of the most common chronic liver conditions globally, presenting a significant public health. Probiotics, as modulators of intestinal microbiota, have emerged attention as a potential therapeutic strategy for managing MASLD. This systematic review and meta-analysis encompassed 12 randomized controlled trials including 657 participants to quantify the effects of probiotic supplementation on liver function indicators, lipid metabolism, and inflammatory markers in MASLD patients. Compared with placebo, probiotics significantly reduced liver-related measures, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyl transaminase (GGT) levels (MDALT: 8.12 IU/L, MDAST: 7.98 IU/L, MDGGT: 6.43IU/L). Meanwhile, probiotics also demonstrated significantly reduction in triglyceride (TG) and total cholesterol (TC) levels (MDTG: 9.35 mg/dL, MDTC: 7.91 mg/dL). Furthermore, probiotics significantly increased high-density lipoprotein cholesterol (HDL-C) levels (MD: 3.31 mg/dL) and decreased low-density lipoprotein cholesterol (LDL-C) levels (MD: 6.31 mg/dL). Given the substantial heterogeneity observed in certain indicators (ALT, AST, TG, HDL-C), a subgroup analysis was conducted. Subgroup analysis revealed that these improvements were more pronounced in adults, though heterogeneity was higher compared to children, indicating more consistent effects in pediatric populations. This study further confirmed the potential value of probiotics in improving liver function and lipid metabolism in patients with MASLD by a rigorous meta-analysis that excluded the influence of potential interfering factors, such as regional factors and publication time. This study provides a better understanding of the individual differences in the effects of probiotic treatment and a solid theoretical basis for the development of relevant intervention products.

7 October 2025 in Foods
Verified
Journal Article
Open access
PDF file
XHXinmeng Huang
Xinmeng Huang
ZZZunqi Zhang
Zunqi Zhang
YLYuanpeng Li
Yuanpeng Li
YYYuting Yang
Yuting Yang
AMAilikemu Mulati
Ailikemu Mulati
JWJiayi Wang
Jiayi Wang
Sugar beet pulp (SBP), a byproduct of the sugar industry, presents significant potential for enhancing economic benefits and promoting sustainable development through its comprehensive utilization. SBP is rich in fiber, with its soluble dietary fiber (SDF) constituting a high-value component. The initial step in the preparation of SDF involves the drying of fresh SBP. This study compares the effects of hot air and microwave drying on the composition, structure, and physicochemical properties of SDF in SBP. Technologies such as gel permeation chromatography, gas chromatography–mass spectrometry, Fourier transform infrared spectroscopy, scanning electron microscopy, and Zeta potential analysis were employed. Results indicated that microwave drying enhanced sugar components in SDF, reduced polysaccharide molecular weight, and formed a uniform and porous microstructure. This resulted in a higher Zeta potential (−24.76 mV) and increased water holding capacity (5.01 g/g). Hot air-dried samples preserved a more intact cell wall network, exhibiting higher swelling capacity (5.18 mL/g). The study demonstrated how both drying methods differentially regulated SDF quality from sugar beet pulp, suggesting that drying process selection should be based on specific application needs.

1 July 2025 in Foods
Verified
Journal Article
Open access
PDF file
DSDilireba Shataer
Dilireba Shataer
SCShaohua Chen
Shaohua Chen
YWYaodan Wu
Yaodan Wu
FLfen liu
fen liu
Haipeng LiuHaipeng Liu
Haipeng Liu
AJAikebaier Jumai
Aikebaier Jumai
Metabolic syndrome has emerged as a significant global public health concern worldwide, characterized by a cluster of interrelated risk factors such as hypertension, hyperlipidemia, hyperglycemia, and abdominal obesity. In recent years, functional foods containing bioactive phytochemicals have attracted considerable scientific interest as potential therapeutic approaches for metabolic syndrome management. Xanthones, a class of naturally occurring tricyclic phenolic compounds abundant in various fruits and medicinal plants, demonstrate diverse biological activities relevant to metabolic health. This comprehensive review examines the dietary sources of xanthones, their bioactivity, and their promising role as functional food components for mitigating metabolic syndrome. The underlying mechanisms of action include modulation of lipid metabolism, improvement of insulin signaling pathways, potent anti-inflammatory and antioxidant effects, and modulation of glucose metabolism. Additionally, we discuss the stability and processing considerations of xanthones in food products. These findings highlight the development of xanthone-enriched functional foods and nutraceuticals as dietary interventions for metabolic syndrome prevention and management. This review comprehensively covers all relevant studies published up to the present without time restrictions.